Impact of Multiphase <sup>68</sup>Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

Abstract

(68)Ga-DOTATOC-PET/CT influences therapeutic management in about one third of patients examined. CT and PET are comparably sensitive, deliver complementary information and equally contribute to therapeutic decision-making. Thus, despite the merits of the PET modality, the CT component must not be neglected and an optimized multiphase CT protocol is recommended.